Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Crit Care Med. 2017 Aug;45(8):1317–1324. doi: 10.1097/CCM.0000000000002514

Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among mechanically ventilated patients in the intensive care unit: a prospective, observational study

Samuel M Brown 1, Abhijit Duggal 2, Peter C Hou 3, Mark Tidswell 4, Akram Khan 5, Matthew Exline 6, Pauline K Park 7, David Schoenfeld 8, Ming Liu 8, Colin K Grissom 1, Marc Moss 9, Todd W Rice 10, Catherine L Hough 11, Emanuel Rivers 12, B Taylor Thompson 13, Roy G Brower 14, with the NIH/NHLBI PETAL Network
PMCID: PMC5511089  NIHMSID: NIHMS870559  PMID: 28538439

Abstract

Objectives

In the contemporary intensive care unit (ICU), mechanically ventilated patients may not have arterial blood gas (ABG) measurements available at relevant timepoints. Severity criteria often depend on ABG results. Retrospective studies suggest that non-linear imputation of PaO2/FIO2 from SpO2/FIO2 is accurate, but this has not been established prospectively among mechanically ventilated ICU patients. The objective was to validate the superiority of non-linear imputation of PaO2/FIO2 among mechanically ventilated patients and understand what factors influence the accuracy of imputation.

Design

Simultaneous SpO2, oximeter characteristics, receipt of vasopressors, and skin pigmentation were recorded at the time of a clinical ABG. ARDS criteria were recorded. For each imputation method, we calculated both imputation error and the area under the curve (AUC) for patients meeting criteria for ARDS (PaO2/FIO2≤300) and moderate-severe ARDS (PaO2/FIO2≤150).

Setting

Nine hospitals within the Prevention and Early Treatment of Acute Lung Injury network.

Patients

We prospectively enrolled 703 mechanically ventilated patients admitted to the emergency departments or ICUs of participating study hospitals.

Interventions

None.

Measurements and Main Results

We studied 1034 ABGs from 703 patients; 650 ABGs were associated with SpO2≤96%. Non-linear imputation had consistently lower error than other techniques. Among all patients, non-linear had a lower error (p<0.001) and higher (p<0.001) AUC (0.87; 95% CI 0.85–0.90) for PaO2/FIO2 ≤300 than linear/log-linear (0.80; 95%CI 0.76–0.83) imputation. All imputation methods better identified moderate-severe ARDS (PaO2/FIO2 ≤150); non-linear imputation remained superior (p<0.001). For PaO2/FiO2≤150, the sensitivity and specificity for non-linear imputation were 0.87 (95% CI 0.83–0.90) and 0.91 (95% CI 0.88–0.93) respectively. Skin pigmentation and receipt of vasopressors were not associated with imputation accuracy.

Conclusions

In mechanically ventilated patients, non-linear imputation of PaO2/FIO2 from SpO2/FIO2 appears accurate, especially for moderate-severe hypoxemia. Linear and log-linear imputation cannot be recommended.

Keywords: Respiratory failure, pulse oximetry, severity scores, Acute Respiratory Distress Syndrome

INTRODUCTION

The ratio of partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FIO2), the PaO2/FIO2 ratio, is commonly used to measure the severity of hypoxemia in patients with respiratory failure. The PaO2/FIO2 ratio is fundamental to the consensus definition of ARDS(1) as well as general critical illness severity indices such as the Sequential Organ Failure Assessment (SOFA) score.(2) Among mechanically ventilated patients, the PaO2/FIO2 ratio may be necessary to diagnose ARDS. However, the PaO2/FIO2 ratio requires that an arterial blood gas (ABG) be obtained to measure PaO2.

Because many clinicians rely on pulse oximetry to evaluate hypoxemia and make adjustments to the mechanical ventilator, patients with ARDS may not have an ABG available in a relevant timeframe for early diagnosis of ARDS or calculation of severity scores. Arterial catheters (which make ABG testing more convenient) are falling out of favor,(3, 4) pulse oximeters have become ubiquitous, and clinicians may use venous blood gases (or exhaled gas sampling) to monitor PCO2 or pH.(5) A non-invasive surrogate for the PaO2/FIO2 ratio, based on measuring the oxyhemoglobin percent saturation with a pulse oximeter, would allow patients without ABGs to be assessed for disease severity and/or evaluated for the hypoxemia criterion for ARDS. To assure equivalence, a non-invasive surrogate for PaO2/FIO2 would require imputation of PaO2 from SpO2. The SpO2/FIO2 ratio has therefore been proposed as a non-invasive surrogate for the PaO2/FIO2 ratio.(611)

The oxyhemoglobin percent saturation can be measured with a pulse oximeter (SpO2), or directly in the arterial blood (SaO2). The relationship between PaO2 and SaO2 (and therefore SpO2) is sigmoidal. However, much prior work investigating the association between SpO2/FIO2 and PaO2/FIO2 ratios employed linear (or log-linear) regression modeling in adults(6, 7) and children.(811)

In a large, retrospective study of patients with ARDS enrolled in three clinical trials,(12) we demonstrated that a non-linear imputation based on the Ellis inversion(13) of the Severinghaus equation(14) outperformed linear and log-linear imputation methods, observations which complemented prior studies of non-intubated patients with pneumonia.(1518) To externally validate these retrospective observations, we undertook a prospective study, with attention to patient characteristics that might affect the accuracy of imputation. We hypothesized that non-linear imputation was superior to other imputation methods and that the receipt of vasopressors and darker skin pigmentation would be associated with less accurate imputation.

MATERIALS AND METHODS

We studied mechanically ventilated patients admitted to the emergency departments (EDs) or intensive care units (ICUs) of participating study hospitals, which were part of the NIH Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. We excluded children, pregnant women, and prisoners. At the time a clinical ABG was obtained for a ventilated patient, the nurse or respiratory therapist obtaining the ABG completed a brief case report form (CRF) that included current SpO2, quality of the oximeter waveform, skin pigmentation (graded informally from very light to very dark, on a 5-point ordinal span, with reference skin pigments included on the CRF). Research coordinators then documented age, sex, body mass index (BMI), body temperature (as measured clinically, without preference for core vs. peripheral temperature measurements), ABG results, basic metabolic panel results, hemoglobin, Positive End Expiratory Pressure (PEEP), FIO2, tidal volume, receipt of vasopressors (i.e., epinephrine, norepinephrine, phenylephrine, dopamine, or vasopressin) at the time the ABG was obtained, and whether the patient met consensus criteria for ARDS other than hypoxemia. Specifically, site investigators individually reviewed chest radiographs and the medical record to assess whether ARDS criteria (acute onset of bilateral lung opacities not fully explained by effusions, lobar/lung collapse, or nodules) other than hypoxemia were met. ARDS was then considered present if the PaO2/FIO2 met relevant thresholds. Given resource constraints, we did not require a specific ABG sampling strategy or collect denominator data on the total number of ABGs performed in participating hospitals.

Data were uploaded to the Clinical Coordinating Center (CCC) at Massachusetts General Hospital, where quality analysis and cleaning were undertaken according to standard procedures. Each participating Institutional Review Board (IRB), including the CCC IRB, approved this study with waiver of informed consent on the basis of compliance with 45 CFR 46.116d.

Statistical analysis

Because imputation is considered to be most accurate for SpO2 ≤ 96%, based on the sigmoidal shape of the hemoglobin-oxygen dissociation curve(14) and our prior empirical observations,(12) we separately analyzed ABGs with an associated SpO2 ≤ 96%. Because PIO2 (partial pressure of inspired oxygen) varies by both FIO2 and barometric pressure, we adjusted PaO2/FIO2 ratios at the Utah site (altitude ~1300m) by the ratio of local to sea level barometric pressure (0.845). We used the Ellis non-linear,(13) Rice linear,(6) and Pandharipande log-linear(7) equations for imputation, as we did in our prior, retrospective work.(12) (The equations are displayed in Table E1.) For purposes of description, we generated Bland-Altman plots of the difference between imputed and measured PaO2/FIO2 as a function of measured PaO2/FIO2 both for all patients and among patients in whom SpO2 ≤ 96%. Secondarily, we calculated the error of the imputations, as well as the proportion of patients in whom the absolute error of the imputation was less than 25 (e.g., if the actual PaO2/FIO2 is 100, then the imputed PaO2/FIO2 is between 75 and 125) or 50 (e.g., if the actual PaO2/FIO2 is 100, then the imputed PaO2/FIO2 is between 50 and 150).

For hypothesis testing, we compared the root mean squared error (RMSE; log transformed given its log normal distribution) of the imputation for each technique, using a paired t test and utilizing generalized estimating equations to account for the fact that some patients contributed multiple ABGs to the analysis.(19) We also calculated area under the receiver operating characteristic curve (AUC) at two diagnostic thresholds for PaO2/FIO2 (150 and 300) for the different imputation techniques. (We note that because linear and log-linear techniques impute PaO2/FIO2 from SpO2/FIO2 monotonically, their AUCs are identical to each other and to raw SpO2/FIO2; because the non-linear technique imputes from SpO2 itself, its AUC can differ.) We used the threshold of ≤ 150 rather than the consensus threshold of ≤ 100 for severe ARDS because it is the threshold used in the PETAL Network’s Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) trial (ClinicalTrials.gov NCT02509078) of neuromuscular blockade in moderate-severe ARDS,(20) following the ACURASYS trial threshold.(21) We compared AUCs using the method of DeLong.(22)

We considered whether other variables would improve the imputation of the PaO2/FIO2, from the point of view of the AUC for predicting that the PaO2/FIO2 was under 300 or under 150. Using linear regression models, we considered PEEP, serum bicarbonate, minute ventilation, FIO2, age, ABG performed during the day (as opposed to at night), SpO2, pulse oximeter location (at the time the ABG was obtained), serum chloride, serum creatinine, and serum sodium (the last three were included in case markers of renal dysfunction or electrolyte imbalance were related indirectly to shifts in the hemoglobin-oxygen dissociation curve), to see whether they improved the accuracy of the imputation.

In a secondary analysis, among the patients for whom more than one ABG was available, we evaluated whether knowledge of the error of measurement on the first ABG improved the imputation for the later ABGs. We attempted multiple complementary techniques to incorporate the first-ABG imputation error into later imputations, including adding the error term, adding a proportion of the error term (derived from linear regression), and the ratio of measured to imputed PaO2/FIO2 ratios.

Analyses were performed in the R Statistical Package version 3.2.3.(23)

RESULTS

We studied 1034 ABGs in 703 patients at 9 hospitals across the United States, among which 650 ABGs were associated with SpO2 ≤ 96%. Patient characteristics are displayed in Table 1. Characteristics of the ABG and associated oximetry measurements are displayed in Table 2. The mean measured PaO2/FIO2 ratio was 226. Relevant laboratory results and ventilator settings are displayed in Tables E2–E3 of the Supplemental Digital Content. Mean PEEP was 7.8 cm H2O; mean tidal volume, corrected for ideal body weight, was 6.9 ml/kg.

Table 1.

Patient Characteristics

Characteristic  Values
Female sex, k/n (%)  292/703 (41.5)
Age, years (± SD)  57.5 ± 16.3 (n = 703)
Height, cm (± SD)  170.1 ± 11.1 (n = 696)
Weight, kg (± SD)  88.6 ± 28.8 (n = 698)
Average PaO2/FIO2 for each patient (± SD)  225.7 ± 111.9 (n = 703)
PaO2/FIO2 ratio, values by threshold§
 PaO2/FIO2 > 300, k/n (%) 166/703 (23.6)
 PaO2/FIO2 ≤ 300, k/n (%) 537/703 (76.4)
 PaO2/FIO2 ≤ 200, k/n (%) 322/703 (45.8)
 PaO2/FIO2 ≤ 150, k/n (%) 188/703 (26.7)
 PaO2/FIO2 ≤ 100, k/n (%) 58/703 (8.3)
# of SpO2 measurements
 1 measurement, k/n (%)  460/703 (65.4)
 2 measurements, k/n (%)  155/703 (22.1)
 3 measurements, k/n (%)  88/703 (12.5)
§

Represents the average of PaO2/FIO2 ratios for each patient

Table 2.

Oximetry and arterial blood gas results

Oximetry.

Variables Values
Patient Located in ICU, k/n (%) 1023/1034 (98.9)
ABG Done during the Day, k/n (%) 714/1034 (69.1)
Pulse Oximeter Location
 Earlobe, k/n (%)  110/1013 (10.9)
 Finger, k/n (%)  806/1013 (79.6)
 Toe, k/n (%)  64/1013 (6.3)
 Forehead, k/n (%)  18/1013 (1.8)
 Other, k/n (%)  15/1013 (1.5)
Pulse Oximeter Type
 Disposable Sensor, k/n (%)  523/1029 (50.8)
 Reusable Sensor, k/n (%)  470/1029 (45.7)
 Flex Sensor, k/n (%)  2/1029 (0.2)
 Forehead (transreflectance) Sensor, k/n (%)  10/1029 (1.0)
 Other, k/n (%)  24/1029 (2.3)
Pulse Oximeter Manufacturer
 Masimo, k/n (%)  785/1034 (75.9)
 Nellcor, k/n (%)  230/1034 (22.2)
 Stryker, k/n (%)  19/1034 (1.8)
SpO2, %  95.0 ± 4.4 (n = 1034)
 SpO2 (where SpO2 ≤ 96%), %  92.8 ± 4.0 (n = 650)
Adequate Pulse Oximeter Waveform, k/n (%)  973/1031 (94.4)
Skin Pigmentation
 Light, k/n (%)  281/1033 (27.2)
 Light/Medium, k/n (%)  429/1033 (41.5)
 Medium, k/n (%)  169/1033 (16.4)
 Medium/Dark, k/n (%)  70/1033 (6.8)
 Dark, k/n (%)  84/1033 (8.13)

ABG Results.

Variables Values

pH  7.36 ± 0.11 (n = 1034)
PCO2, mmHg  42.3 ± 12.6 (n = 1034)
PaO2, mmHg  98.1 ± 51.4 (n = 1034)
SaO2, %  93.8 ± 4.4 (n = 932)
Hgb, g/dL  9.8 ± 2.2 (n = 891)
Methemoglobin, %  0.8 ± 0.4 (n = 533)
Carboxyhemoglobin, %  1.4 ± 0.7 (n = 536)
Temperature at time of ABG, °C  37 ± 1 (n = 1030)
On a vasopressor at time of ABG, k/n (%)  388/1034 (37.5)

ICU: Intensive Care Unit; ABG: arterial blood gas; Hgb: hemoglobin

As displayed in Figure 1, Bland-Altman plots suggested that non-linear imputation was accurate, albeit with decreasing accuracy at higher PaO2/FIO2 ratios. This appeared true, especially for measured PaO2/FIO2 ratio ≤ 150 and for SpO2 ≤ 96%. In Table 3, we quantitatively describe the performance of the different imputation techniques. Non-linear imputation had lower RMSE than log-linear or linear imputation methods for all ABGs and for ABGs where SpO2 ≤ 96% (all p<0.001).

Figure 1. Bland-Altman plots of imputed vs. measured PaO2:FIO2 ratios.

Figure 1

Bland-Altman plot of the difference between measured and imputed PaO2/FIO2 ratios. Black represents non-linear, red linear, and blue log-linear imputation results.

Table 3.

Comparison of error by imputation technique

Imputation technique Mean absolute error Standard deviation of error P value (comparison with non-linear imputation)* Proportion of ABGs with error§ < 25 mmHg (%) Proportion of ABGs with error§ < 50 mmHg (%)
All ABGs (N=1034)
Non-linear 54.3 69.6 NA 48.7 68.8
Linear 63.5 73 <0.001 33.1 59.7
Log-linear 60.3 66.1 <0.001 28.6 61.7
ABGs with SpO2 ≤ 96% (N=650)
Non-linear 30.2 45.4 NA 65.1 84.9
Linear 41.2 44.6 <0.001 40.9 72.3
Log-linear 40.7 36.9 <0.001 31.5 73.5
ABGs where other ARDS criteria are met (N=417)
Non-linear 43.9 61.5 NA 55.9 75.8
Linear 47.3 58.2 <0.001 40.5 71
Log-linear 48.1 49.6 <0.001 28.1 69.1
ABGs with SpO2 ≤ 96% where other ARDS criteria are met (N=297)
Non-linear 26.4 44.9 NA 68.7 88.9
Linear 36.9 44.3 <0.001 45.5 77.4
Log-linear 40.6 37.1 <0.001 27.9 74.7
*

From a paired t-test of log-transformed root-mean-square error

§

Absolute value of error

ABG: arterial blood gas; ARDS: Acute Respiratory Distress Syndrome

All imputation methods displayed good to excellent discrimination, as outlined in Table 4, with AUCs ranging from 0.77 (95% CI 0.73–0.81) to 0.96 (95% CI 0.94–0.97) for different thresholds and sub-populations. Non-linear imputation had a significantly higher AUC than linear/log-linear imputation (p<0.001), with AUCs ranging from 0.86 (95% CI 0.82–0.89) to 0.96 (95% CI 0.94–0.97). The superiority of non-linear imputation was true for PaO2/FIO2 ≤ 150 and PaO2/FIO2 ≤ 300. AUCs were consistently higher for the lower threshold (≤150) than for the higher threshold (≤300). The observed AUCs were compatible with good sensitivity and specificity. At the PaO2/FiO2 ≤ 150 threshold, the sensitivity and specificity for non-linear imputation were 0.87 (95% CI 0.83–0.90) and 0.91 (95% CI 0.88–0.93), respectively. At the PaO2/FIO2 ≤ 300 threshold, sensitivity and specificity were 0.90 (95% CI 0.88–0.92) and 0.67 (95% CI 0.61–0.73), respectively.

Table 4.

AUC for severe ARDS and any ARDS

Severe ARDS (PF ratio ≤ 150)



Imputation method All ABGs (N = 1034)
Other ARDS criteria are met (N = 421)
Other ARDS criteria are NOT met (N = 613)
Area 95% CI Area 95% CI Area 95% CI
Nonlinear 0.95 (0.94, 0.97) 0.94 (0.92, 0.96) 0.96 (0.94, 0.97)
Linear/log-linear 0.92 (0.90, 0.93) 0.91 (0.88, 0.94) 0.92 (0.90, 0.94)

All ARDS (PF ratio ≤ 300)

Nonlinear 0.87 (0.85, 0.90) 0.87 (0.81, 0.93) 0.86 (0.82, 0.89)
Linear/log-linear 0.80 (0.76, 0.83) 0.84 (0.77, 0.91) 0.76 (0.72, 0.81)

AUC: Area under the receiver operating characteristic curve; ABG: Arterial blood gas; ARDS: Acute Respiratory Distress Syndrome

The results were generally similar for the 650 ABGs associated with SpO2 ≤ 96% (see Tables 3, E4). In this group, AUC analysis yielded similar results, except for patients who otherwise met ARDS criteria at the PaO2/FiO2 ≤ 300 threshold, where discrimination was only good: AUCs were 0.77 to 0.81. The decrease in AUC appeared related to the relatively small number of individuals with SpO2 ≤ 96% who also had PaO2/FiO2 > 300 and otherwise met criteria for ARDS. Among ABGs in patients that otherwise met ARDS criteria, restricting to ABGs with SpO2≤96% again demonstrated the superiority of non-linear imputation (Table 3).

In our analysis to understand whether certain variables (e.g., skin pigmentation, oximeter sensor location, oximeter manufacturer, vasopressor use, PEEP, and others, as outlined in methods) were associated with changes in the accuracy of imputation, models incorporating those predictors yielded negligible improvement in the accuracy of the imputation. The AUC of the imputations increased at most by 1%. Notably, only 5.6% of ABGs were associated with an inadequate pulse oximeter waveform.

Similarly, when evaluating whether results from an initial ABG result could improve the accuracy of imputation for later ABGs, none of the techniques materially improved the accuracy of imputation.

DISCUSSION

In this large, prospective, multi-center study of clinical ABGs obtained in mechanically ventilated ICU patients, we externally validated prior retrospective observations that a non-linear imputation is best for estimating the degree of hypoxemia from pulse oximetry. While all tested imputations had reasonable accuracy among mechanically ventilated patients, a non-linear, physiologically based approach appeared best overall, especially when the PaO2/FIO2 ratio is low. Among patients who otherwise met ARDS criteria, accuracy was highest when restricted to ABGs where SpO2≤96%.

The AUC analysis, which is most relevant to screening for the presence of hypoxemia consistent with ARDS, confirms that physiologically based, non-linear imputation of PaO2/FIO2 is superior to other imputation techniques. These estimates are less accurate for patients with higher SpO2 and SpO2/FIO2 values. Contrary to our initial expectation, no variables were associated with greater or lesser accuracy to a substantial degree, suggesting that routine use of this technique would not require measurement of additional variables. In this respect, our findings differ from prior studies suggesting a relationship between PEEP and the accuracy of PaO2/FIO2 imputation.(6, 7) Because only one in twenty of study ABGs were associated with a low quality pulse oximeter waveform, we suspect that it is reasonable to restrict such imputations to situations where the waveform is of adequate quality. Based on physiological principles and our subgroup analysis, it also seems reasonable to restrict evaluation to ABGs where SpO2≤96%, perhaps by downward titration of FIO2 in patients with high SpO2.

Our study has two key strengths differentiating it from prior studies of the imputation of PaO2/FIO2 from SpO2/FIO2 among patients with and at risk for ARDS, including our own retrospective work:(12) it is prospective—with real-time correlation of SpO2 and PaO2—and is multi-center. Our study design allowed us to evaluate, in a generalizable fashion, the accuracy of imputation and the relevance of the oximeter waveform, the oximeter type(24) and location, as well as skin pigmentation,(24, 25) body temperature, and other relevant parameters.

Our study has limitations. Because of resource limitations, we were unable to record all ABGs in study ICUs and were unable to obtain outcome data for study patients. We are thus unable to exclude ascertainment bias, which could affect generalizability, and we cannot determine whether inaccurate imputation is associated with mortality or other patient outcomes. For the patients in whom an ABG was associated with SpO2 ≤ 96% the prevalence of PaO2/FIO2 > 300 was so uncommon, especially among patients who met other criteria for ARDS, that the AUC was a less reliable measure of accuracy. The error associated with non-linear imputation was still lower than for the other imputation techniques. Nevertheless, identification of mild ARDS may be somewhat more difficult on the basis of SpO2/FiO2. While the non-linear imputation equation is too complex to calculate easily by hand, we provide a lookup table (Table E5); a similar lookup table has been employed in the ROSE study protocol for screening.

CONCLUSIONS

Because the association between SpO2 and PaO2 is physiologically sigmoidal, the use of a non-linear imputation strategy appears preferable to other strategies for estimating PaO2/FIO2 from pulse oximetry. Such an imputation strategy displays good discrimination for ARDS at relevant diagnostic thresholds, albeit with lower specificity for mild ARDS, particularly when SpO2 is allowed to remain >96% with high FIO2. The use of linear or log-linear imputation methods can no longer be recommended.

Supplementary Material

Supplemental Data File _.doc_ .tif_ pdf_ etc._

Acknowledgments

We thank the nurses and respiratory therapists at Intermountain Medical Center, Cleveland Clinic, Brigham and Women’s Hospital, Baystate Medical Center, OHSU Hospital, Ohio State University Wexner Medical Center, University of Michigan Hospital, Harborview Medical Center, and Henry Ford Hospital who graciously participated in this work.

Source of Funding: The sponsor (the National Heart, Lung, and Blood Institute) funds the PETAL Network for which this work was performed. The sponsor had no role in the analysis or reporting of the data. This study was supported by the National Institutes of Health, National Heart Lung and Blood Institute, Prevention and Early Treatment of Lung Injury Network, contracts U01HL123010, U01HL123004, U01HL123022, U01HL122989, U01HL123008, U01HL123027, U01HL123020, U01HL123018, U01HL123031, U01HL123033, U01HL122998, U01HL123023, U01HL123009. Samuel M. Brown is supported by the National Institutes of Health, Heart Lung and Blood (R21HL123433).

Footnotes

Address for Reprints: Samuel M. Brown, MD MS, Shock Trauma Intensive Care Unit, 5121 South Cottonwood Street, Murray, UT 84107, Telephone: 801-507-6556, Fax: 801-507-5578, Samuel.Brown@imail.org, No reprints will be ordered

Conflicts of Interest: The author(s) declare that they have no competing interests.

Copyright form disclosure: Drs. Brown, Hou, Tidswell, Khan, Exline, Park, Schoenfeld, Liu, Grissom, Moss, Rice, Hough, Rivers, Thompson, and Brower received support for article research from the National Institutes of Health (NIH). Dr. Khan’s institution received funding from United Therapeutics, GlaxoSmithKline, Actelion Pharmaceuticals, and the NIH/National Heart, Lung, and Blood Institute (NHLBI). Dr. Exline disclosed that OSU is a member of the Prevention and Early Treatment of Acute Lung Injury (PETAL) network (NHLBI), and he received other support as an expert witness for medical malpractice cases. Dr. Park’s institution received funding from the NIH, National Institute of Allergy and Infectious Diseases, Bristol Myers Squibb, and National Board of Medical Examiners. Dr. Schoenfeld’s institution received funding from the NHBLI; and he received funding from Alexion Pharmaceuticals, Inc., Baker Botts LLP, Boston Biostatistics Research Foundation, Brainstorm Cell Therapeutics Inc., Cardeas, Lavin Consulting LLP, Mitsubishi Pharma, North Shore Hospital, Pfizer, and Purdue Pharma, L.P. Dr. Liu received funding from the NHLBI. Dr. Grissom’s institution received funding from the NIH, NHLBI, and the NIH/NHLBI PETAL Network. Dr. Rice received funding from GlaxoSmithKline, Avisa Pharma, and Cumberland Pharmaceauticals. Dr. Hough’s institution received funding from the NHBLI. Dr. Rivers’ institution received funding from Abbott Laboratories, Alere, Spectral Diagnostics, Lajolla Pharmaceutical, Health Decisions, and the NIH. Dr. Thompson received funding from consultancy for Alexion, Asahi Kasei, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Vertex, and Regeneron. Dr. Brower’s institution received funding from the NIH/NHLBI, and he received funding from Applied Clinical Intelligence and Global Therapeutics.

Dr. Duggal disclosed that he does not have any potential conflicts of interest.

This work was completed at Intermountain Medical Center, Cleveland Clinic, Brigham and Women’s Hospital, Baystate Medical Center, OHSU Hospital, Ohio State University Wexner Medical Center, University of Michigan Hospital, Harborview Medical Center, and Henry Ford Hospital.

References

  • 1.ARDS Definition Task Force. Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. doi: 10.1001/jama.2012.5669. [DOI] [PubMed] [Google Scholar]
  • 2.Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–710. doi: 10.1007/BF01709751. [DOI] [PubMed] [Google Scholar]
  • 3.Garland A, Connors AF., Jr Indwelling arterial catheters in the intensive care unit: necessary and beneficial, or a harmful crutch? Am J Respir Crit Care Med. 2010;182(2):133–134. doi: 10.1164/rccm.201003-0410ED. [DOI] [PubMed] [Google Scholar]
  • 4.Garland A. Arterial lines in the ICU: a call for rigorous controlled trials. Chest. 2014;146(5):1155–1158. doi: 10.1378/chest.14-1212. [DOI] [PubMed] [Google Scholar]
  • 5.Bloom BM, Grundlingh J, Bestwick JP, et al. The role of venous blood gas in the emergency department: a systematic review and meta-analysis. Eur J Emerg Med. 2014;21(2):81–88. doi: 10.1097/MEJ.0b013e32836437cf. [DOI] [PubMed] [Google Scholar]
  • 6.Rice TW, Wheeler AP, Bernard GR, et al. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132(2):410–417. doi: 10.1378/chest.07-0617. [DOI] [PubMed] [Google Scholar]
  • 7.Pandharipande PP, Shintani AK, Hagerman HE, et al. Derivation and validation of Spo2/Fio2 ratio to impute for Pao2/Fio2 ratio in the respiratory component of the Sequential Organ Failure Assessment score. Crit Care Med. 2009;37(4):1317–1321. doi: 10.1097/CCM.0b013e31819cefa9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Khemani RG, Patel NR, Bart RD, 3rd, et al. Comparison of the pulse oximetric saturation/fraction of inspired oxygen ratio and the PaO2/fraction of inspired oxygen ratio in children. Chest. 2009;135(3):662–668. doi: 10.1378/chest.08-2239. [DOI] [PubMed] [Google Scholar]
  • 9.Khemani RG, Thomas NJ, Venkatachalam V, et al. Comparison of SpO2 to PaO2 based markers of lung disease severity for children with acute lung injury. Crit Care Med. 2012;40(4):1309–1316. doi: 10.1097/CCM.0b013e31823bc61b. [DOI] [PubMed] [Google Scholar]
  • 10.Thomas NJ, Shaffer ML, Willson DF, et al. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11(1):12–17. doi: 10.1097/PCC.0b013e3181b0653d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lobete C, Medina A, Rey C, et al. Correlation of oxygen saturation as measured by pulse oximetry/fraction of inspired oxygen ratio with Pao2/fraction of inspired oxygen ratio in a heterogeneous sample of critically ill children. J Crit Care. 2013;28(4):538 e531–537. doi: 10.1016/j.jcrc.2012.12.006. [DOI] [PubMed] [Google Scholar]
  • 12.Brown SM, Grissom CK, Moss M, et al. Nonlinear Imputation of Pao2/Fio2 From Spo2/Fio2 Among Patients With Acute Respiratory Distress Syndrome. Chest. 2016;150(2):307–313. doi: 10.1016/j.chest.2016.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ellis RK. Determination of PO2 from saturation. Journal of applied physiology. 1989;67(2):902. doi: 10.1152/jappl.1989.67.2.902. [DOI] [PubMed] [Google Scholar]
  • 14.Severinghaus JW. Simple, accurate equations for human blood O2 dissociation computations. Journal of applied physiology: respiratory, environmental and exercise physiology. 1979;46(3):599–602. doi: 10.1152/jappl.1979.46.3.599. [DOI] [PubMed] [Google Scholar]
  • 15.Lanspa MJ, Jones BE, Brown SM, et al. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. Journal of hospital medicine: an official publication of the Society of Hospital Medicine. 2013;8(2):83–90. doi: 10.1002/jhm.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dean NC, Jones JP, Aronsky D, et al. Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department. Ann Emerg Med. 2012;59(1):35–41. doi: 10.1016/j.annemergmed.2011.07.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brown SM, Jones BE, Jephson AR, et al. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med. 2009;37(12):3010–3016. doi: 10.1097/CCM.0b013e3181b030d9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sanz F, Dean N, Dickerson J, et al. Accuracy of PaO/FiO calculated from SpO for severity assessment in ED patients with pneumonia. Respirology. 2015 doi: 10.1111/resp.12560. [DOI] [PubMed] [Google Scholar]
  • 19.Van Belle G. Statistical Rules of Thumb. Hoboken: J. Wiley & Sons; 2008. [Google Scholar]
  • 20.Huang DT, Angus DC, Moss M, et al. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) Trial for Acute Respiratory Distress Syndrome. Annals of the American Thoracic Society; 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–1116. doi: 10.1056/NEJMoa1005372. [DOI] [PubMed] [Google Scholar]
  • 22.DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. [PubMed] [Google Scholar]
  • 23.R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. [Google Scholar]
  • 24.Feiner JR, Severinghaus JW, Bickler PE. Dark skin decreases the accuracy of pulse oximeters at low oxygen saturation: the effects of oximeter probe type and gender. Anesth Analg. 2007;105(6 Suppl):S18–23. doi: 10.1213/01.ane.0000285988.35174.d9. tables of contents. [DOI] [PubMed] [Google Scholar]
  • 25.Bickler PE, Feiner JR, Severinghaus JW. Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology. 2005;102(4):715–719. doi: 10.1097/00000542-200504000-00004. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data File _.doc_ .tif_ pdf_ etc._

RESOURCES